Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes by Joshi, A & Woodman, O
?Thank
?
??????
???????
??????
?
?
Citatio
See th
Version
Copyri
Link to
??
?
you for do
??????????
??????????
??????????
n: 
is record i
:
ght Statem
 Published
?
wnloading
??????????
?????????????
??????????????????????????????????????????
n the RMI
ent: ©  
 Version:
 this docum
????????????
??????????
T Researc
ent from 
??????????
?
h Reposit
the RMIT R
??????????
ory at:  
esearch R
??????????
epository
??????????
????
??
PLEASE DO NOT REMOVE THIS PAGE
Joshi, A and Woodman, O 2012, 'Increased nitric oxide activity compensates for increased
oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes',
Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 385, no. 11, pp. 1083-1094.
http://researchbank.rmit.edu.au/view/rmit:20564
Accepted Manuscript
2012 Springer-Verlag.
http://dx.doi.org/10.1007/s00210-012-0794-3
  
 
 
 
INCREASED NITRIC OXIDE ACTIVITY COMPENSATES FOR INCREASED 
OXIDATIVE STRESS TO MAINTAIN ENDOTHELIAL FUNCTION IN RAT AORTA IN 
EARLY TYPE 1 DIABETES 
 
A.Joshi1 and O.L.  Woodman1,2* 
1 Department of Pharmacology, University of Melbourne, Victoria, Australia. 
Email: anjali.jo@gmail.com 
2School of Medical Sciences, RMIT University, Bundoora, Victoria,  Australia. 
Email: owen.woodman@rmit.edu.au 
 
*Correspondence:  
Professor Owen Woodman 
School of Medical Sciences 
RMIT University 
PO Box 71 Bundoora  
Victoria 3083 Australia 
Tel: +61(03) 9925 7305 
Fax: +61(03) 9925 7063 
Email: owen.woodman@rmit.edu.au 
 2 
RUNNING TITLE: Oxidative stress in diabetic endothelial dysfunction 
ABSTRACT 
Purpose: Hyperglycaemia and oxidative stress are known to acutely cause endothelial dysfunction 
in vitro, but in the initial stages of diabetes endothelium-dependent relaxation is preserved. The aim 
of this study was to investigate how endothelium-dependent relaxation is maintained in the early 
stages of type-1 diabetes.  
Methods: Diabetes was induced in Sprague-Dawley rats with a single injection of streptozocin (48 
mg/kg, i.v.) and after 6 weeks endothelium-dependent and -independent relaxation was examined in 
the thoracic aorta in vitro. Lucigenin-enhanced chemiluminescence was used to measure superoxide 
generation from the aorta.  
Results: Diabetes increased superoxide generation by the aorta (2180±363 vs 986±163 AU/mg dry 
tissue weight). ACh-induced relaxation was similar in aortae from control (pEC50 7.36±0.09, Rmax 
95±3%) and diabetic rats (pEC50 7.33±0.10, Rmax 88±5%). The ACh-induced relaxation was 
abolished by the combined presence of the NOS inhibitor L-NNA (100µM) and an inhibitor of 
soluble guanylate cyclase,  ODQ (10 µM) in control rats but under the same conditions the diabetic 
aortic rings showed significant relaxation to ACh (pEC50 6.75±0.15, Rmax 25±4%, p<0.05). In 
diabetic aortae the addition of haemoglobin, which inactivates nitric oxide, to L-NNA+ODQ 
abolished the response to ACh. The addition of the potassium channel blockers, apamin and 
TRAM-34 to L-NNA+ODQ also abolished the relaxation response to ACh. Diabetes significantly 
elevated plasma total nitrite/nitrate and increased expression of eNOS and calmodulin in aortae.  
Conclusions: These data indicate that after 6 weeks of diabetes, despite increased oxidant stress, 
endothelium-dependent relaxation is maintained due to the increased eNOS expression resulting in 
increased NO synthesis. In diabetic arteries NO acts both through, and independently of, cGMP 
pathways to cause relaxation.  
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INTRODUCTION 
Cardiovascular complications are the major cause of morbidity and mortality in diabetic patients 
(Lopes-Virella et al., 2008). The pathogenic role of glucose in cardiovascular disease is increasingly 
apparent, as confirmed by studies carried out both on diabetic and non-diabetic patients (Bartnik et 
al., 2007). Acute hyperglycaemia (3-6 hrs) induces endothelial dysfunction of the aorta as well as of 
the renal circulation of non-diabetic rabbits (Gomes et al., 2004) and numerous studies report that 
long-term hyperglycaemia leads to endothelial dysfunction in various animal models of diabetes 
(Pieper et al., 1998, Pieper, 1999, Csanyi et al., 2007) and in humans (Johnstone et al., 1993). 
Hyperglycaemia both acute (Goel et al., 2007) and chronic (Karasu, 2000) is known to induce 
oxidative stress and it has been proposed that oxidative stress leads to endothelial dysfunction 
(Ammar et al., 2000, Hink et al., 2001, Jay et al., 2006). It is surprising then to note that there are 
several reports that endothelial function is normal after a short duration (2-4 weeks) of diabetes 
despite the presence of hyperglycaemia (Orie et al., 1993, Pieper, 1999, Shen et al., 2003).  
Pieper (1999) reported a triphasic effect of diabetes on endothelial function. Initially endothelium-
dependent relaxation was increased after 1 week of diabetes followed by a normal response after 2 
weeks and impaired response after 8 weeks of diabetes. While the mechanism of endothelial 
dysfunction has been extensively studied in long–term diabetes, it still remains to be elucidated how 
endothelium-dependent relaxation is maintained in the early stages of type-1 diabetes.  
The endothelium produces vasodilators such as nitric oxide, prostacyclin and a still unidentified, 
endothelium-derived hyperpolarising factor (EDHF) (Bryan et al., 2005).  Nitric oxide is considered 
to be the main endothelium-derived relaxing factor in larger arteries (Clark and Fuchs, 1997). The 
major source of nitric oxide in the endothelium is endothelial nitric oxide synthase (eNOS) but a 
small amount of nitric oxide may also be released from preformed endothelial nitrosothiol stores 
(Alencar et al., 2003, Lima et al., 2010).  
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There are several possible mechanisms that may contribute to the  maintenance of endothelial 
function in short-term diabetes e.g. increased production of nitric oxide (Stadler et al., 2003), 
increased expression of eNOS (Hink et al., 2001)  or a compensatory upregulation of the release 
other vasodilators (Shi et al., 2006, Malakul et al., 2008, Nacci et al., 2009). Several studies have 
shown increased nitric oxide production in the early stages of diabetes. Stadler et al. (2003) reported 
increased production of nitric oxide in aortae from diabetic rats for a limited time after induction of 
diabetes (up to 7 weeks). There are conflicting reports regarding expression of eNOS at various 
stages of diabetes. Hink et al. (2001) showed an increased expression of eNOS but decreased basal 
nitric oxide in aortae after 2 weeks of diabetes leading the authors to propose that eNOS became 
uncoupled and shift towards superoxide rather than nitric oxide synthesis whereas Bojunga et al. 
(2004) reported a decreased expression of eNOS in diabetic aorta but increased production of nitric 
oxide. On the other hand, increased expression of inducible NOS has also been demonstrated in 
diabetic rat aorta and heart (Bojunga et al., 2004, Jesmin et al., 2006). Overall it has been 
demonstrated that whereas diabetes induces endothelial dysfunction by decreased synthesis or 
increased breakdown of nitric oxide (Beckman and Crow, 1993, Jay et al., 2006) in the longer term 
but it is yet not clear what changes take place in early diabetes to maintain endothelial function 
despite hyperglycaemia and oxidant stress. 
As there has been limited  investigation of the the mechanism of relaxation in early diabetes (Shen 
et al., 2003, Abboud et al., 2009) the purpose of this study was to gain better understanding of 
mechanism of endothelium-dependent relaxation in the early stages of type-1 diabetes before 
acetylcholine-induced relaxation is impaired with a focus on the determination of the role of various 
endothelium-derived vasodilators in maintaining endothelial function in the presence of increased 
oxidative stress.  
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METHODS 
Animals 
Male Sprague-Dawley rats (200-230 g, 8 weeks, Animal Resource Centre, Perth, WA) were housed 
2-3 per cage, fed standard rat chow and had free access to food and water. All the experiments were 
performed according to the guidelines of the National Health and Medical Research Council of 
Australia and approved by the Animal Ethics Committees of the University of Melbourne and 
RMIT University.   
Induction of diabetes 
Diabetes was induced in rats by a single injection of streptozotocin (48 mg/kg) dissolved in 0.1 M 
citrate buffer (pH 4.5) into the tail vein after an overnight fast. Control rats received an injection of 
citrate buffer. Blood glucose was measured at the time of experiment for all groups using an Accu-
Check Advantage II monitor (Roche, Mannheim, Germany). The rats showing blood glucose of >20 
mmol/L were considered to be diabetic. 
Preparation of aortic rings 
The rats were killed 6 weeks after streptozotocin or vehicle injection by exposure to a mixture of 
halothane and oxygen for 5 min. The chest was opened and the thoracic aorta was isolated. After 
removing superficial fat and connective tissue, the thoracic aorta was cut into 2-3 mm long rings 
and mounted in organ baths in Krebs bicarbonate solution (118 mM NaCl, 4.7 mM KCl, 1.18 mM 
MgSO4, 1.2 mM KH2PO4, 25 mM NaHCO3, 11.1 mM D-glucose, and 1.6 mM CaCl2), bubbled 
with 5% CO2 in O2 at 37°C to assess vascular function. Blood plasma was collected for NOx assay 
and from some of the rats, the thoracic aorta was isolated and immediately frozen for western 
blotting.  
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Functional experiments 
The aortic rings, mounted in organ baths at a resting tension of 1g, were equilibrated for 60-90 min 
with the bath medium changed every 15 min. The tissues were maximally contracted by exposure to 
physiological saline solution containing a high potassium concentration of 123 mM. Endothelial 
integrity was determined by measuring the relaxation caused by exposure to acetylcholine (10 P-5 PM) 
in phenylephrine-precontracted rings and the endothelium was considered to be intact if the 
preparation relaxed by greater than 80%. Cumulative concentration response curves to acetylcholine 
and sodium nitroprusside were determined using rings submaximally contracted with phenylephrine 
(10 P-8 P to 10P-7P M). Responses to acetylcholine and sodium nitroprusside were also tested in the 
presence or absence of N-nitro-L-arginine (L-NNA, 100µM) a nitric oxide synthase (NOS)  
inhibitor, 1H-[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 µM) a soluble guanylate cylase 
(sGC) inhibitor , indomethacin (10 µM) a cyclooxygenase inhibitor, apamin (1µM) a small 
conductance calcium P Pactivated potassium channel  (SKRCaR) blocker , TRAM-34 (1µM) an 
intermediate conductance calcium activated potassium channel (IKRCaR) blocker, haemoglobin (20 
µM) a nitric oxide scavenger ,  carboxy-PTIO (20 mM) a scavenger of NO˙ and L-cysteine (1 mM) 
a scavenger of NO.P־ P   
11BLucigenin-enhanced chemiluminescence assay  
Lucigenin-enhanced chemiluminescence was used to measure superoxide release from aortic rings 
that were not used in the functional experiments, using a previously described procedure (Chan et 
al., 2003). At the conclusion of the assay, tissues were dried for 48 h at 65°C to allow superoxide 
production to be normalized to dry tissue weight. The results were expressed as superoxide counts 
per mg tissue. 
12BWestern blot analysis 
Western blots were performed as described previously (Woodman et al., 2004) with the following 
modifications. The aortic tissues were homogenized and the total protein concentration of the 
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samples was quantified using a Bradford assay. Equal amounts of protein homogenate were 
subjected to SDS-PAGE and western blot analysis with mouse antibodies against eNOS, inducible-
NOS, caveolin-1 (Transduction Laboratories), calmodulin (Millipore), NADPH oxidase (NOX)-2 
and heme oxygenase-1 (AbCAM). To normalize for the amount of protein loaded on the gels, 
membranes were reprobed with a loading control antibody (β-tubulin, AbCAM). All proteins were 
detected by enchanced chemiluminescence (Amersham) after incubation with anti-mouse secondary 
antibody. All protein bands were quantified by densitometry (Biorad Chemidoc) and expressed as a 
ratio of the loading control.  
Nitrite estimation 
The level of nitric oxide metabolites (NOx, ie. nitrite + nitrate) was measured in plasma using a 
colorimetric assay kit (Roche Diagnostics). Plasma samples were stored at -80°C until assayed. The 
concentration of NOx was measured in samples of plasma after converting all nitrates to nitrite with 
nitrate reductase. Total nitrite levels were measured in duplicate by absorbance at 560 nm using the 
Griess reaction. The calibration curve was prepared using sodium nitrite as a standard. 
Drugs 
Acetylcholine perchlorate (BDH Chemicals), apamin (Sigma), L-cysteine (Sigma), p-
hydroxymercuribenzoic acid (Sigma) and phenylephrine hydrochloride (Sigma) were all dissolved 
in distilled water. Haemoglobin (Sigma) and sodium nitroprusside (Sigma) were dissolved in Krebs 
solution. Indomethacin (Sigma) was dissolved in 0.1M sodium carbonate and L-NNA (Sigma) was 
dissolved in 0.1 M sodium bicarbonate. Ethacrynic acid (Sigma), ODQ (Cayman), carboxy-PTIO 
(Cayman) and TRAM-34 (Sigma) were dissolved in dimethyl sulfoxide. The final concentrations of 
DMSO in the bath were 0.0001%-0.01% while performing the functional experiments which has 
been shown to have no effect on vasorelaxation in these concentrations.    
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Analysis and statistics 
Concentration-response data were fitted to a sigmoidal plot using GraphPad Prism version 5.0, 
which estimated the pEC50. Statistical analysis was carried out using Student’s unpaired t-test or 
multiple comparisons were performed using analysis of variance (ANOVA) followed by a 
Bonferroni post test. p<0.05 was considered statistically significant. All values are presented as 
mean±SEM. Each n represents the number of animals per group. 
 10 
RESULTS 
Blood glucose and body weight 
The control and diabetic animals had a similar initial body weight but diabetic animals had a 
significantly lower body weight at the end of 6 weeks compared to control animals (Table 1). All of 
the diabetic animals exhibited hyperglycaemia at the time of experiment.  
Vascular superoxide  
Superoxide counts measured from segments of thoracic aorta were significantly higher in diabetic 
animals compared to control animals using the lucigenin-enhanced chemiluminescence assay. 
Diphenyliodonium, a non-selective inhibitor of NADPH oxidase, reduced the amount of superoxide 
generation in both groups (Table 1).  
Plasma nitrite concentrations 
The diabetic animals showed significantly higher plasma NOx concentration compared to control 
animals (Table 1).  
Endothelium-dependent and endothelium-independent relaxation  
6 weeks after streptozotocin injection, endothelium-dependent and endothelium-independent 
relaxation to acetylcholine (10-10 to 10-5 M) and sodium nitroprusside (10-11 to 10-5 M) respectively 
were similar in aortae from control and diabetic animals (Figure 1).  
Effect of L-NNA, ODQ and indomethacin on relaxation  
The presence of L-NNA or ODQ completely abolished acetylcholine-induced relaxation in control 
aortae (Figure 2). In the aortic rings from diabetic animals the relaxation was partially inhibited, but 
not abolished, by L-NNA or ODQ (Figure 2b). Pretreatment with indomethacin had no effect on 
relaxation to either ACh or SNP in normal or diabetic animals (Figure 2). The diabetic animals 
showed a higher sensitivity to the nitric oxide donor sodium nitroprusside in the presence of L-
NNA and ODQ compared to control animals.  
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Effect of nitric oxide scavengers on relaxation 
The presence of the nitric oxide scavenger haemoglobin in addition to L-NNA+ODQ abolished the 
relaxation response to acetylcholine in diabetic aortae (Figure 3a). The presence of haemoglobin 
significantly decreased the pEC50 to sodium nitroprusside in control as well as diabetic aortae. 
Carboxy-PTIO and L-cysteine also significantly decreased the pEC50 and Rmax to acetylcholine in 
diabetic aorta when used in combination with L-NNA (Figure 3). The pEC50 and Rmax values for 
acetylcholine and sodium nitroprusside in the presence of these inhibitors are shown in Tables 2 and 
3. 
Effect on relaxation of agents depleting nitrosothiol stores  
The role of preformed nitrosothiol stores in relaxation response to acetylcholine in diabetic aorta 
was examined using nitrosothiol depleting agent ethacrynic acid (EA) and p-
hydroxymercuribenzoic acid (PHMBA). The aortic rings were incubated for 20 minutes with L-
NNA with or without ethacrynic acid or PHMBA. After the first exposure of acetylcholine, the 
rings incubated with ethacrynic acid or PHMBA showed significantly less relaxation compared to 
L-NNA incubated rings (Figure 4). After the second exposure to acetlycholine, the ethacrynic acid 
and PHMBA incubated rings showed contraction indicating a complete depletion of nitrosothiol 
stores. 
Effect of potassium channel blockers on relaxation  
 The presence of apamin plus Tram-34 had no effect on vasorelaxation to acetylcholine or to 
sodium nitroprusside in control aortae (Figure 2c) whereas in diabetic animals they significantly 
decreased the maximum relaxation to acetylcholine (Figure 2d) but had no effect on sodium 
nitroprusside responses (Table 3). In diabetic animals the relaxation to acetylcholine observed in the 
presence of ODQ plus L-NNA was abolished by addition of apamin and TRAM-34 (Figure 2d) and 
the maximum response to sodium nitroprusside was significantly decreased compared to control 
aortae (Table 3).  
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Protein expression by western blot analysis 
The expression of eNOS, calmodulin and NADPH oxidase-2 was found to be significantly 
increased in aortae from the diabetic group compared to control (Figure 5). The eNOS dimer-
monomer ratio was significantly decreased in diabetic aorta. The expression of caveolin and heme 
oxygenase-1 was not altered by diabetes. Inducible NOS expression was not detected in either of 
the groups (data not shown). 
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DISCUSSION 
Our study showed that, despite an increase in oxidative stress, endothelium-dependent and 
endothelium-independent relaxation of the rat aorta was unaltered in the early stages of diabetes, 
but the mechanism of endothelium-dependent relaxation had been changed. We found that 
endothelium-dependent relaxation of diabetic aortae was resistant to inhibition by a NOS inhibitor 
and/or inhibition of sGC and that the remaining component of relaxation was sensitive to SKCa and 
IKCa channel blockers as well as nitric oxide scavengers. In diabetic arteries the nitrosothiol 
depleting agents also abolished the relaxation response to acetylcholine that persisted in the 
presence of L-NNA. Western blot analysis showed increased expression of eNOS and calmodulin in 
diabetic aortae, which may explain the increase in nitric oxide synthesis, indicated by the elevation 
in plasma nitrite levels. These results suggest that despite increased oxidative stress, endothelial 
function was maintained in early diabetes due to a compensatory increased activity of nitric oxide 
which acted primarily through activating soluble guanylate cyclase and partly through the opening 
of potassium channels.  In diabetes, nitrosothiol stores acted as the additional source of nitric oxide 
in addition to eNOS. 
Hyperglycaemia increases superoxide production by several mechanisms, including 
autooxidation of glucose, activation of polyol pathways, and generation of advanced glycation end 
products (Jay et al., 2006). Several enzymes are involved in the production of ROS at a vascular 
level such as cyclooxygenase, NADPH oxidase and xanthine oxidase (Ellis and Triggle, 2003). In 
vascular disease, uncoupling of NOS also accounts for the increased ROS production. In this study 
diabetic animals showed an increase in oxidative stress measured by production of superoxide 
counts using lucigenin-enhanced chemiluminescence. We also found increased expression of 
NADPH oxidase -2 in diabetic rat aorta compared to control animals (Figure 5). Diphenyliodonium, 
a non-selective inhibitor of NADPH oxidase enzyme, blocked the production of superoxide in 
lucigenin assay (Table 1) suggesting that NADPH oxidase is the major source of superoxide. The 
dimer-monomer ratio of eNOS was decreased in diabetic animals (Figure 5) suggesting eNOS was 
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uncoupled form and therefore may also contribute to superoxide production. These results are 
consistent with other studies which have shown increased oxidative stress (Bitar et al., 2005, Ding 
et al., 2007) as well as increased activity/expression of NADPH oxidase, p22 phox and p67phox 
subunits in diabetes (Wendt et al., 2005, Guo et al., 2007).  
Hyperglycaemia, both acute and chronic, has been widely reported to cause endothelial 
dysfunction. Rat aortic rings showed a diminished response to endothelium-dependent vasodilator 
when incubated with high glucose for 2-6 hrs (Gomes et al., 2004, Goel et al., 2007, Fang et al., 
2009). By contrast, diabetic animals have shown variable endothelium-dependent relaxation 
responses depending upon the duration of diabetes (Pieper, 1999). In the early stages of diabetes (1-
6 weeks of induction), it has been reported that endothelium-dependent relaxation is unaltered (Orie 
et al., 1993, Garcia et al., 1999) or increased in rats (Altan et al., 1989) or mice (Shen et al., 2003). 
By contrast, there are numerous studies which have reported decreased relaxation responses in 
various animal models of long-term diabetes (8 weeks or more) (Oyama et al., 1986, Garcia-Pascual 
et al., 1995, Bitar et al., 2005, Alper et al., 2006). Whilst the mechanism of endothelial dysfunction 
has been widely explored in long-term diabetes, it is yet to be established why endothelium-
dependent relaxation is either unchanged or increased in early diabetes.   
In aortae, the endothelium-dependent relaxation is normally mediated entirely by nitric 
oxide through the activation of sGC (Clark and Fuchs, 1997).  This was confirmed by complete 
blockade of acetylcholine-induced relaxation by the NOS inhibitor, L-NNA or the sGC inhibitor 
ODQ in control animals. By contrast, aortae from the diabetic animals showed significant relaxation 
in the presence of L-NNA, ODQ or the combination of both. We postulated that this might be due 
to increased nitric oxide activity or that there might be a compensatory up-regulation of another 
non-nitric oxide pathway of relaxation.  We investigated the possibility of increased nitric oxide 
activity by using nitric oxide scavengers, in combination with L-NNA and ODQ. The L-NNA and 
ODQ resistant relaxation to acetylcholine was found to be sensitive to haemoglobin (Figure 3a) and 
was also significantly decreased by L-cysteine, a scavenger of NO- or carboxy-PTIO (scavenger of 
 15 
NO˙), suggesting an increased nitric oxide activity in diabetes as well as advocating potential 
contribution of both NO˙ and NO- in acetylcholine-induced relaxation in diabetes.  Haemoglobin has 
also been shown to bind nitrosothiol (Kim-Shapiro et al., 2006) and previous studies have shown 
that pre-formed stores of nitric oxide could exist in vascular tissue in the form of nitrosothiols and 
nitric oxide in the form of NO˙/NO- could be released from these stores by acetylcholine even in the 
presence of a NOS inhibitor (Ng et al., 2007). Nitrosothiol-derived compounds have been suggested 
to be potent vasodilators (Myers et al., 1990, Bates et al., 1991) which may cause relaxation 
mediated by both sGC and the opening of SKCa and IKCa channels (Batenburg et al., 2009) and 
recent reports suggest a physiological role for NO- in spreading vasodilation (Yuill et al., 2011). It 
is also interesting to note that vasorelaxant responses to nitroxyl donors are maintained in the 
presence of oxidant stress (Bullen et al., 2011) supporting the possibility that NO- might contribute 
to relaxation in diabetes.  Our results using nitrosothiol depleting agents (Figure 4) also support a 
contribution of nitric oxide released from pre-formed nitrosothiol stores towards endothelium-
dependent relaxation in early diabetes. This is consistent with the observations of Ng et al. (2007) 
who found concluded that relaxation caused by ultraviolet light involved release of pre-formed NO 
stores that was unaffected by type 2 diabetes. 
In our study diabetic animals showed a significant increase in total plasma nitrite/nitrate 
levels (Table 1) consistent with earlier reports that demonstrated increased nitrite levels in short 
term (4 weeks) diabetes (Bojunga et al., 2004). Stadler et al. (2003) found increased nitric oxide 
levels in diabetic aorta starting from 2 weeks up to 7 weeks after diabetes induction. We also 
observed increased expression of eNOS protein in diabetic aorta (Figure 5) but inducible NOS was 
not detected. Several studies in diabetes had reported an upregulated, but dysfunctional, uncoupled 
NOS leading to increased oxidative stress and endothelial dysfunction (Hink et al., 2001, Satoh et 
al., 2005) and we also found a lower expression for the eNOS dimer and higher expression for the 
eNOS monomer indicating uncoupling and the potential to generate superoxide rather than nitric 
oxide. A further possibility is that in the presence of elevated oxidant stress the consequent 
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depletion of BH4 could promote the synthesis of NO- rather than NO by eNOS as previously 
reported (Rusche et al., 1998, Adak et al., 2000).  We also investigated expression of two proteins 
that modulate eNOS activity (i.e. calmodulin and caveolin-1). The constitutively expressed eNOS is 
catalytically inactive when bound to caveolin-1, however, calmodulin displaces caveolin-1 in the 
presence of calcium and binds to eNOS and thereby activates eNOS to produce nitric oxide (Frank 
et al., 2007) . We found that the expression of calmodulin was significantly increased while 
expression of caveolin-1 remained unchanged in diabetes. Takahashi and Mendelsohn (2003) 
reported that calmodulin causes concentration dependent increases in eNOS activity in vitro and we, 
and others, have reported that an increase in calmodulin expression in vivo is associated with an 
increase in eNOS activity (Sobey et al., 2004, Woodman et al. 2004, Vera et al., 2007).  This 
suggested that eNOS activity may be increased due to increased calmodulin binding despite a 
decreased dimer formation in diabetic aorta. Therefore, diabetic animals may produce more nitric 
oxide due to increased eNOS activity, to resist endothelial dysfunction caused by increased 
oxidative stress. There have been conflicting findings regarding eNOS regulation in diabetic 
animals with reports of both  an increased (Stockklauser-Färber et al., 2000) or decreased (Komers 
et al., 2006) expression.  Stockklauser-Färber et al. (2000) found that initially cardiac NOS 
expression and activity increased to a maximum after 4-6 weeks of diabetes and then decreased 
afterwards. They suggested that high glucose could lead to induction of eNOS in the early stages of 
diabetes in response to increased ROS production as the increase in eNOS could be blocked by 
antioxidant treatment. In a recent study, Riad et al. (2008) found a marked decrease in eNOS 
expression in diabetic skeletal muscle after 8 weeks of streptozotocin injection and stimulation of 
eNOS production by eNOS transcription enhancer AVE3085 improved endothelial function and 
reduced oxidative stress and vascular inflammatory responses. Taken together, our results suggested 
a compensatory increase in basal nitric oxide levels to combat increased oxidative stress in diabetic 
aorta. 
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The endothelial SKCa and IKCa channels have been reported to contribute to ACh-induced 
endothelial hyperpolarization and NO-mediated relaxation in large arteries (Stankevicius et al., 
2006). It is also reported that opening of SKCa and IKCa channels decreases myogenic tone and 
increases ACh-induced relaxation in rat cremaster arterioles (Sheng et al., 2009) and restores 
attenuated EDHF-type relaxation in mesenteric small arteries from Zucker diabetic fatty rats 
(Brondum et al., 2010). Also recent studies have suggested that SKCa and IKCa channel opening is 
associated with the activation of NO synthase and NO production (Stankevicius et al., 2006, Sheng 
and Braun, 2007, Brahler et al., 2009, Sheng et al., 2009, Dalsgaard et al., 2010). The production of 
endothelium-dependent relaxing factors generally involves an increase in the intracellular Ca2+ 
concentration [Ca2+]i. An increase in endothelial [Ca2+]i will open calcium-activated potassium 
channels of small (SKCa) and intermediate (IKCa) conductance, thereby hyperpolarizing the 
endothelial cell. A recent study showed that the SKCa and IKCa channel opener NS309-induced 
calcium influx that contributed to the formation of NO (Stankevicius et al., 2011). However, further 
studies are required to clarify how activation of these mechanisms is coupled to increased formation 
of NO in endothelial cells.  
CONCLUSION 
Previous studies have suggested that even acute hyperglycaemia (Bartnik et al., 2007, 
Cameron and Cruickshank, 2007) or long term diabetes i.e. 8 weeks or more (Hink et al., 2001, 
Peredo et al., 2006) could lead to endothelial dysfunction due to increased oxidative stress and 
decreased nitric oxide bioavailability. We suggest that, in diabetes, an initial increased synthesis of 
nitric oxide by increased activity of eNOS might be able to compensate for increased oxidative 
stress leading to preserved endothelial function at the start of diabetes followed by a final reduction 
in endothelium response as the disease progresses leading to endothelial dysfunction. In the light of 
these findings, we can conclude that despite marked hyperglycaemia and increased oxidative stress, 
endothelium-dependent and -independent relaxation was maintained after 6 weeks of 
streptozotocin-induced diabetes due to increased nitric oxide bioavailability. The increase in nitric 
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oxide bioavailability could be attributed to increased expression of eNOS and calmodulin and/or 
release from nitrosothiol stores. The nitric oxide could be acting through sGC as well as a sGC-
independent pathway through activation of SKCa and IKCa channels to cause relaxation in diabetic 
rat aorta. Therefore our results suggest that increased nitric oxide bioavailability is a compensatory 
mechanism to counteract increased oxidative stress in the early stages of diabetes to maintain 
endothelial function in aorta. 
 
 
ABBREVIATIONS: 
EDHF, endothelium-derived hyperpolarising factor; eNOS, endothelial nitric oxide synthase; sGC, 
soluble guanylate cyclase; ODQ, 1H-(1,2,4)-oxadiazolo(4,2-a)quinoxalin-1-one; L-NNA, N-nitro-
L-arginine; TRAM-34, 1-[(2-chlorophenyl)(diphenyl)methyl]-1H-pyrazole;; IKCa, intermediate-
conductance calcium activated potassium channel; SKCa, small-conductance calcium-activated 
potassium channel; ROS, reactive oxygen species; PHMBA, p-hydroxymercuribenzoic acid. 
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LEGENDS FOR FIGURES: 
 
Figure 1:  Effect of 6 weeks of diabetes on endothelium-dependent and endothelium-independent 
relaxation responses to (a) acetylcholine (10-10 to 10-5 M) and (b) sodium nitroprusside (10-11 to 10-5 
M) in phenylephrine (10-8 to 10-7 M) precontracted aortic rings. The data is expressed as 
mean±SEM. The pEC50 and Rmax values calculated from the data are shown in Table 2.  
 
Figure 2: Concentration response curve to ACh in a) control b) diabetic animals in the presence of 
(●) vehicle, (♦) N-nitro-L-arginine (L-NNA), (□) ODQ, (∆) indomethacin and c) control d) diabetic 
animals in the presence of (●) vehicle, (◊) L-NNA+ODQ, (■) Apamin+TRAM-34, (∇) L-
NNA+ODQ+Apamin+TRAM-34 in phenylephrine (10-8 to 10-7 M) preconstricted aortic rings. The 
data is expressed as mean±SEM. The pEC50 and Rmax values calculated from the data are given in 
Tables 2 and 3. 
 
Figure 3: Concentration response curve to acetylcholine (ACh) in diabetic animals in the presence 
of a) (●) vehicle, (◊) L-NNA+ ODQ, (♦) Hb+ODQ, (□) Hb+L-NNA+ODQ and b) (●) vehicle, (♦) 
L-NNA, (□) L-NNA+carboxy-PTIO, (∆) L-NNA+L-cysteine in phenylephrine (10-8 to 10-7 M) 
preconstricted aortic rings. All the experiments were performed in the presence of indomethacin. 
The data is expressed as mean±SEM. The pEC50 and Rmax values calculated from the data is given 
in Tables 3 and 4. 
 
Figure 4: Effect of the nitrosothiol depleting agents ethacrynic acid (50 µM) and p-
hydroxymercuribenzoic acid (10 µM) on relaxation responses to three consecutive exposures to 
ACh (10 µM) in the presence of L-NNA (100 µM). All experiments were performed in the presence 
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of indomethacin (10 µM). * Significantly different compared to L-NNA treated rings (one way 
ANOVA, Bonferroni post test, p<0.05). n=4 for each data set. 
 
Figure 5: Protein expression of (a) eNOS, (b) calmodulin (c) NOX2 and (d) eNOS dimer-monomer 
in the normal and diabetic rat aorta determined by Western blot analysis. Diabetes significantly 
increased the expression of all the proteins in the rat aorta. Results are shown as mean±s.e.m. 
*Significantly different from control rats (Student’s unpaired t-test, p<0.05). 
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Table1: Initial and final body weights, blood glucose, superoxide counts from aortic rings and 
plasma nitrite levels in control and diabetic animals.  
 
 Control Diabetic 
Initial body weight (g) 268±13 245±8 
Final body weight (g) 451±7 306±14* 
Blood glucose (mmol/L) 9.8±1 >33* 
Superoxide counts (AU/mg dry 
tissue weight) 
986±163 2180±363* 
Superoxide counts in the 
presence of DPI (AU/mg dry 
tissue weight) 
112±18 177±53 
Plasma nitrite levels (µmol/L) 114±16 272±68* 
 
The data is expressed as mean±SEM.  
*Significantly different from control group (Student’s unpaired t-test, p<0.05). 
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Table 2: Parameters for endothelium-dependent and independent relaxation in response to ACh and 
SNP in aortic rings from control and diabetic rats. The effects of L-NNA (100 µM), ODQ (10 µM) 
and indomethacin (Indo, 10 µM) on responses to ACh and SNP are shown.  
 
 
 Control Diabetic 
 n pEC50 Rmax n pEC50 Rmax 
ACh 
Vehicle 7 7.36±0.1 92±4 7 7.34±0.11 88±5 
L-NNA 7 ND 10±6* 7 6.78±0.1* 54±7*# 
ODQ 7 ND 6±4* 7 6.77±0.15* 46±13*# 
Indo 7 7.43±0.1 91±4 7 7.48±0.12 93±2 
SNP 
Vehicle 7 8.13±0.14 100±0 7 8.57±0.27 101 ±2 
L-NNA 7 8.74±0.24* 101±1 7 9.35±0.16*# 101±2 
ODQ 7 5.80±0.34* 50±11* 7 6.54±0.07*# 55±6* 
Indo 7 8.10±0.19 95±4 7 8.59±0.15 101±2 
 
The data is expressed as mean±SEM. 
 n= number of experiments 
ND= not determined 
* Significantly different compared to vehicle in the same treatment group (one way ANOVA, 
Bonferroni post test, p<0.05). 
 #Significantly different compared to the control group (Student’s unpaired t-test, p<0.05). 
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Table 3: The effect of various treatments on responsed to ACh and SNP in aortic rings from control 
and diabetic rats. All the experiments were performed in the presence of indomethacin. The 
combination of apamin+TRAM-34 had no effect on relaxation in any of the group. ODQ+L-NNA+ 
apamin +TRAM-34 treatment completely abolished relaxation in both the groups. Responses to 
ACh in the diabetic group showed a resistance to inhibition by L-NNA+ODQ, but were abolished 
by additional presence of Hb.   
 Control Diabetic 
 n pEC50 Rmax n pEC50 Rmax 
ACh 
Vehicle 6 7.49± 0.1 90±1 6 7.45±0.2 93±5 
L-NNA +ODQ 6 ND 1±1* 6 6.75±0.15* 25±4*# 
Apamin+Tram-34 6 7.34± 0.13 89±2 6 7.43±0.11 81±5* 
L-NNA +ODQ+ 
Apamin+Tram-34 
6 ND 2±2* 6 ND 6±4* 
Hb+ODQ 6 ND 0* 6 ND 15±5* 
Hb+ODQ+ L-
NNA 
6 ND 4±4* 6 ND 0* 
SNP 
Vehicle 6 8.32± 0.15 99.4±0.4 6 8.33±0.17 98±3 
L-NNA +ODQ 6 5.94± 0.10* 61±3* 6 6.76±0.19*# 56±6* 
Apamin+Tram-34 6 8.03 ± 0.21 99.6±0.7 6 8.30±0.18 100±0.7 
L-NNA +ODQ+ 
Apamin+Tram-34 
6 5.93 ± 0.09* 57±4* 6 6.28±0.09* 33±10*# 
Hb+ODQ 6 6.56±0.12* 85±7* 6 6.46±0.05* 68±22* 
Hb+ODQ+ L-
NNA 
6 6.46±0.10* 84±4* 6 6.61±0.12* 85±5 
The data is expressed as mean±SEM. n= number of experiments 
ND= not determined 
* Significantly different compared to vehicle in the same treatment group (one way ANOVA, 
Bonferroni post test, p<0.05).  # Significantly different compared to the same treatment group from 
the control animals (Student’s unpaired t-test, p<0.05). 
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Table 4: The effect of the NO scavenger carboxy-PTIO and L-cysteine on pEC50 and Rmax in aortic 
rings from diabetic rats for ACh concentration response curve. All these experiments were 
performed in the presence of indomethacin.  
 
Treatment 
 
Diabetic 
 n pEC50 Rmax 
ACh 
Vehicle 7 7.19±0.08 93±3 
L-NNA  7 6.69±0.14* 44±6* 
L-NNA+PTIO 6 6.33±0.06* 26±4*# 
L-NNA +L-cys 5 6.23±0.23* 15±6*# 
 
The data is expressed as mean±SEM. n= number of experiments 
* Significantly different compared to vehicle (one way ANOVA, Bonferroni post test, p<0.05). 
# Significantly different compared to L-NNA (one way ANOVA, Bonferroni post test, p<0.05). 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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